| Pharmacogenomics | |
| Former Names: | --> |
| Abbreviation: | Pharmacogenomics |
| Discipline: | Pharmacogenomics |
| Editor: | David Gurwitz, Howard McLeod, Munir Pirmohamed |
| Publisher: | Future Medicine Ltd |
| History: | 2000–present |
| Frequency: | 18/year |
| Impact: | 2.350 |
| Impact-Year: | 2016 |
| Issn: | 1462-2416 |
| Eissn: | 1744-8042 |
| Coden: | PARMFL |
| Oclc: | 55059877 |
| Website: | http://www.futuremedicine.com/loi/pgs |
| Link5: | --> |
| Link5-Name: | --> |
Pharmacogenomics is a peer-reviewed medical journal established in 2000 and published by Future Medicine. The editors-in-chief are David Gurwitz (Tel-Aviv University), Howard McLeod (University of North Carolina at Chapel Hill), and Munir Pirmohamed (University of Liverpool). The journal covers the field of pharmacogenomics.
The journal is abstracted and indexed in Biological Abstracts, BIOSIS Previews, Biotechnology Citation Index, Chemical Abstracts, Current Contents/Life Sciences, EMBASE/Excerpta Medica, Index Medicus/MEDLINE/PubMed, Science Citation Index, and Scopus. According to the Journal Citation Reports, the journal has a 2016 impact factor of 2.350, ranking it 132nd out of 256 journals in the category "Pharmacology & Pharmacy".[1]